Advanced Accelerator Applications USA, Inc drugs
3 results
Lutathera (lutetium lu 177 dotatate)
(Lutetium Lu 177 dotatate)Advanced Accelerator Applications USA, Inc
Usage: LUTATHERA is indicated for treating adult and pediatric patients aged 12 and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), encompassing foregut, midgut, and hindgut neuroendocrine tumors.
Netspot (68ga-dotatate)
(68Ga-DOTATATE)Advanced Accelerator Applications USA, Inc
Usage: NETSPOT, after gallium-68 radiolabeling, is indicated for use with positron emission tomography (PET) to localize somatostatin receptor-positive neuroendocrine tumors (NETs) in both adult and pediatric patients.
Pluvicto (lutetium lu 177 vipivotide tetraxetan)
(lutetium Lu 177 vipivotide tetraxetan)Advanced Accelerator Applications USA, Inc
Usage: PLUVICTO is indicated for adult patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibitors and are suitable for delaying taxane-based chemotherapy or have previously received such chemotherapy.